Abstract:Annexin A1 (ANXA1) is a calcium-binding protein involved in arachidonic acid metabolism and epidermal growth factor receptor tyrosine kinase pathway. ANXA1 has been implicated in early squamous cell carcinogenesis of esophagus and correlates with degree of tumor differentiation. Our goal was to evaluate ANXA1 expression its correlation with different chemoradiation therapy (CRT) sensitivity and determine its prognostic significance in esophageal squamous cell carcinoma (ESCC). Immunohistochemical staining was used to assay the expression of ANXA1 in 60 patients (14 stage II, 6 stage III, and 40 stage IV) who underwent concurrent CRT from August 2007 to June 2011, and the clinical stage was determined according to the International Union against Cancer (UICC) Tumor-node-metastasis (TNM) 2002 classification. ANAX1 expression level was classified as positive (≥5% of tumor cells with cytoplasmic staining), negative (<5% of tumor cells with cytoplasmic staining), or negative; and was correlated with clinicopathologic features and patients' outcomes. The tissues were classified into responders group (completely remission, CR) and non- responders group (stable disease, SD) by endoscopy, according to the WHO Response Evaluation Criteria in Solid Tumors. The total positive expression rates of ANX A1 was 55.0% (33 of 60). Sixty patients were evaluable for response. There were 11 (18.4%) complete remission, 20 (33.3%) partial remission, 20 (33.3%) stable disease, and 9 (15.0%) progression disease. the positive expression rate of ANX A1 in responders was 72.7% (8 of 11), while 45.0% (9 of 20) in non-responders (p > 0.05). The expression of ANX A1 was not significantly correlated with patients’ age, gender, tumor location, tumor differentiation grade, T stage, N stage and clinical TNM stage (p > 0.05). In univariate analysis, overall survival correlated significantly with tumor differentiation grade (p = 0.004), short-term effect (p < 0.001, TNM stage (p = 0.039), Karnofsky performance status (p = 0.001) and ANXA1 expression (p = 0.050). Subgroup analysis for patients with stage IV, Patient with negative ANX A1 (n = 19) had significantly shorter median survival times than those with positive ANXA1 (n = 21) (11.4 months vs 13.1 months, p = 0.039). Our results indicate that positive ANXA1 expression is frequent in esophageal squamous cell carcinoma. The expression of ANX A1 was not associated with chemoradiation therapy sensitivity. However, it maybe serves as a novel prognostic biomarker for ESCC.

Overexpression of ANXA2 predicts adverse outcomes of patients with malignant tumors: a systematic review and meta-analysis

ANXA2 is correlated with the molecular features and clinical prognosis of glioma, and acts as a potential marker of immunosuppression

Clinical significance of Annexin A2 expression in oral squamous cell carcinoma and its influence on cell proliferation, migration and invasion

Prognostic and Diagnostic Significance of Annexin A2 in Colorectal Cancer.

Correlation Study of Annexin A2 and Prognosis of Glioblastoma

Association of annexin A2 with cancer development (Review).

LncRNA HOXA‐AS2 is a prognostic and clinicopathological predictor in patients with cancer: A meta‐analysis

Overexpression of Annexin A2 Promotes Proliferation by Forming a Glypican 1/C-Myc Positive Feedback Loop: Prognostic Significance in Human Glioma

[Expression of annexin A1 (ANXA1) and A2 (ANXA2) and its significance in benign and malignant lesions of gallbladder].

The Association between ANXA2 mutations and Clinical Pathological Features in Patients with Breast Cancer

Annexin-1 Downregulation is Associated with Clinical Outcome in Chinese Patients with Hilar Cholangiocarcinoma

Down-regulation of annexin II in prostate cancer is associated with Gleason score, recurrence, metastasis and poor prognosis.

HOXA-AS2 may predict the prognosis of solid tumors among Chinese patients: A meta-analysis and bioinformatic analysis

Association of serum annexin A1 with treatment response and prognosis in patients with esophageal squamous cell carcinoma

Increased Level of Phosphorylation-Annexin A2 is Associated with Higher Tumor Stage and Poor Prognosis in Colorectal Adenocarcinomas

ANXA2 is a Potential Marker for the Diagnosis of Human Cervical Cancer

Expression of ANXA1 in Metastasis Carcinoma of Lymph Node in Gastric Cancer and Its Relationship with Prognosis

Expression of Annexin A5 is Associated with Higher Tumor Stage and Poor Prognosis in Colorectal Adenocarcinomas.

Annexin A9 promotes invasion and metastasis of colorectal cancer and predicts poor prognosis

The Negative Expression of Annexin A1 in Esophageal Squamous Cell Carcinoma is Associated with Poor Outcome

ANXA1: An Important Independent Prognostic Factor and Molecular Target in Glioma